Hearing Aids for Tinnitus: The Short Answer
Hearing aids are most likely to reduce tinnitus when co-existing hearing loss is present. In a randomised controlled trial of 114 patients with high-frequency sensorineural hearing loss, 71–74% achieved a clinically meaningful reduction in tinnitus distress within three months of wearing hearing aids (Yakunina et al. (2019)). For people with normal hearing, amplification is not recommended and carries a real risk of making symptoms worse. Whether hearing aids will help you depends almost entirely on whether hearing loss is part of your picture.
The Promise and the Reality of Hearing Aids for Tinnitus
With dozens of articles ranking the “best hearing aids for tinnitus” and audiologist websites promising relief, it is easy to come away thinking that hearing aids are a straightforward fix. They are not, or at least, not for everyone.
If you are researching this because you are tired of the ringing and wondering whether a hearing aid is worth hundreds or thousands of dollars, your scepticism is well placed. The marketing often runs ahead of the evidence. Some clinics promote combination devices with built-in sound generators as a premium solution; the RCT data does not support the extra cost.
This article skips the product rankings and focuses on what actually determines whether hearing aids help: your specific type of tinnitus and whether hearing loss is part of it. The evidence comes from randomised controlled trials and clinical guidelines, not manufacturer claims.
Why Hearing Loss Is the Key Variable in Hearing Aids for Tinnitus
To understand why hearing loss matters so much, it helps to know what researchers believe is happening in the brain when tinnitus develops.
When the cochlea (the inner ear) is damaged by noise, age, or illness, it sends fewer signals up the auditory nerve. The brain responds by turning up its own internal sensitivity to compensate, a process researchers call central gain. This compensatory hyperactivity is thought to generate the phantom sound you perceive as tinnitus. A hearing aid restores the peripheral sound input that has been reduced, which in turn can dial down the brain’s over-amplified response.
This mechanism only applies when hearing loss is genuinely driving the process. For someone with a normal audiogram, the brain is not compensating for missing input, so there is no peripheral deficit for a hearing aid to correct. Amplification in that situation does not address the underlying cause and, as the clinical guidelines make clear, may cause harm.
Roughly 90% of people with chronic tinnitus have measurable co-existing hearing loss (Hearing Aids and Masking Devices for Tinnitus), which means the majority of tinnitus patients are at least potential candidates for amplification. The question is whether their individual profile makes them a good fit.
What the Evidence Actually Shows
The evidence on hearing aids for tinnitus sits across three tiers, and reading all three together gives the most accurate picture.
RCT data: the best available outcomes
Yakunina et al. (2019) conducted a double-blind randomised controlled trial with 114 patients who had high-frequency sensorineural hearing loss and chronic tinnitus. Participants wore hearing aids for three months, then stopped. At the three-month mark, 71–74% across all three device groups achieved a reduction of at least 20% on the Tinnitus Handicap Inventory (THI), a validated scale measuring how much tinnitus disrupts daily life. At six months (three months after discontinuing the devices), 52–59% maintained that level of improvement. Critically, all three amplification strategies performed equally well, and standard fitting was sufficient.
A separate RCT by Henry et al. (2017) compared conventional hearing aids, combination instruments (hearing aid plus built-in sound generator), and extended-wear hearing aids in 55 patients. Average Tinnitus Functional Index scores improved by 21 points in the standard hearing aid group and 33 points in the combination group, but the difference was not statistically significant. The study’s own conclusion was that there is “insufficient evidence to conclude that any of these devices offers greater relief from tinnitus than any other one tested” (Henry et al. (2017)).
Clinical guidelines: what they recommend
The UK’s NICE guideline (NG155) sets out a three-tier framework: offer amplification to tinnitus patients whose hearing loss affects communication; consider it when hearing loss is present but communication is unaffected; and do not offer amplification to people with tinnitus but no hearing loss, with the explicit warning that “amplified sound may induce a hearing loss” (National (2020)).
A systematic review comparing 10 clinical practice guidelines found that hearing aids were not unanimously recommended across guidelines, in contrast to counselling and CBT, which appeared in all of them (Meijers et al. (2023)).
The Cochrane caveat
The Cochrane systematic review by Sereda et al. (2018) pooled eight RCTs with 590 participants examining hearing aids, sound generators, and combination devices. Its conclusion is the most sobering in the evidence base: there is no trial data comparing any sound therapy device against a waiting list or placebo control. All comparisons are device against device. This means the within-group improvements seen in trials like Yakunina could partly reflect natural history or placebo effects rather than the device itself. The Cochrane review rated all evidence as low quality and concluded it “cannot support the superiority of any sound therapy option over another” (Sereda et al. (2018)).
What this means in practice: the evidence is genuinely encouraging, particularly for patients with high-frequency hearing loss, but individual results vary and no definitive efficacy claim holds up against the most rigorous methodological standard.
Who Is Most Likely to Benefit — and Who Isn’t
Your likelihood of benefiting from a hearing aid depends substantially on which of three profiles fits you.
Profile 1: Tinnitus with confirmed hearing loss (especially high-frequency)
This is the group with the strongest evidence behind them. The Yakunina et al. (2019) RCT was specifically designed for patients with this profile, and the 71–74% response rate at three months is the most concrete outcome figure available. The benefits may extend beyond tinnitus itself: a prospective study by Zarenoe et al. (2017) found that patients with both tinnitus and hearing loss showed significantly greater improvements in working memory and sleep quality after hearing aid fitting than patients with hearing loss alone. If you are in this group and have not yet tried a properly fitted hearing aid, the evidence supports giving it a real trial.
Profile 2: Tinnitus without measurable hearing loss
Hearing aids are not recommended for this group. The NICE guideline is explicit: do not offer amplification devices to people with tinnitus but no hearing loss (National (2020)). The central gain mechanism that hearing aids address depends on peripheral hearing loss being present. Without it, there is no audiological deficit for the device to correct. For people who also have hyperacusis (increased sensitivity to sound), amplification carries an additional risk of worsening that sensitivity. If this is your profile, evidence-based options include cognitive behavioural therapy (CBT) and other neurologically focused approaches.
Profile 3: Tinnitus with hearing loss, but standard hearing aids haven’t helped
Combination instruments, devices that combine amplification with a built-in sound generator, are sometimes marketed as the next step. The Henry et al. (2017) RCT found numerically greater TFI improvement with combination devices (33 points versus 21 points for standard hearing aids), but the difference did not reach statistical significance in a trial of 55 participants. The study was likely underpowered to detect a true difference if one exists, but on current evidence, the added cost of a combination device is not clearly justified. Patients in this group should discuss the options with an audiologist who specialises in tinnitus, rather than assuming a more expensive device will deliver more relief.
If you are in Profile 1 or Profile 3, the single most useful step is a formal audiological evaluation before any purchase decision.
Features Worth Looking For — and Marketing Claims to Ignore
If you have confirmed hearing loss and are considering a hearing aid, a few practical points are worth knowing before you visit a clinic or browse options.
Open-fit or receiver-in-canal (RIC) styles avoid blocking the ear canal, which is relevant for tinnitus patients because occluding the canal can amplify the internal perception of the ringing. These styles allow natural sound to enter alongside amplified sound.
Frequency-specific fitting calibrated to your audiogram is standard in any prescription device. The Yakunina et al. (2019) trial found that frequency-lowering strategies offered no additional tinnitus benefit over conventional fitting, so there is no evidence basis for paying a premium for specialist frequency-shifting algorithms marketed for tinnitus.
Bluetooth streaming capability is useful for connecting hearing aids to sound therapy apps, which some patients find helpful as a complement to amplification.
Built-in tinnitus masking programmes are a legitimate add-on feature, and many prescription devices include them. The evidence does not show they outperform amplification alone (Sereda et al. (2018)), but they do no harm and some patients find them useful for specific situations, like quiet environments at night.
On OTC versus prescription: over-the-counter hearing aids are more affordable and now available in the US following FDA regulatory changes in 2022, but they require self-fitting. For tinnitus management specifically, audiologist-fitted devices calibrated to your individual audiogram are preferable. Self-fitting is unlikely to adequately address the specific frequency profile that drives your particular tinnitus.
Conclusion: The Bottom Line on Hearing Aids for Tinnitus
Hearing aids are among the better-supported practical interventions for tinnitus, but the evidence applies specifically to people with co-existing hearing loss, and the realistic outcome is reduced distress, not silence.
If you have tinnitus and have never had a formal hearing test, that is the right first step. If hearing loss is confirmed, a properly fitted hearing aid has meaningful RCT evidence behind it and is a reasonable first-line option. If your hearing tests as normal, amplification is not the answer and could make things worse. CBT and other approaches have stronger support for your profile.
A good audiologist will tell you honestly whether a hearing aid makes sense for your situation. If your hearing is normal and they still want to sell you a device, that is a signal to seek a second opinion.
